Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review).

Soeiro-DE-Souza MG, Dias VV, Missio G, Balanzá-Martinez V, Valiengo L, Carvalho AF, Moreno RA.

Exp Ther Med. 2015 Mar;9(3):643-652. Epub 2015 Jan 23.

2.

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. Review.

3.

Targeting memory processes with drugs to prevent or cure PTSD.

Cain CK, Maynard GD, Kehne JH.

Expert Opin Investig Drugs. 2012 Sep;21(9):1323-50. doi: 10.1517/13543784.2012.704020. Epub 2012 Jul 27. Review.

5.

Use of antipsychotics in the treatment of post-traumatic stress disorder.

Adetunji B, Mathews M, Williams A, Budur K, Mathews M, Mahmud J, Osinowo T.

Psychiatry (Edgmont). 2005 Apr;2(4):43-7.

6.

Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.

Norrholm SD, Jovanovic T.

Neuropsychiatr Dis Treat. 2010 Sep 7;6:517-32. doi: 10.2147/NDT.S10951.

7.

Emerging targets for antidepressant therapies.

Rakofsky JJ, Holtzheimer PE, Nemeroff CB.

Curr Opin Chem Biol. 2009 Jun;13(3):291-302. doi: 10.1016/j.cbpa.2009.04.617. Epub 2009 Jun 6. Review.

8.

Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome.

Jin H, Lanouette NM, Mudaliar S, Henry R, Folsom DP, Khandrika S, Glorioso DK, Jeste DV.

J Clin Psychopharmacol. 2009 Jun;29(3):210-5. doi: 10.1097/JCP.0b013e3181a45ed0.

9.

Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.

Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, Figueira I.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):169-80. doi: 10.1016/j.pnpbp.2008.12.004. Epub 2008 Dec 24. Review.

10.

Psychopharmacotherapy of posttraumatic stress disorder.

Kozaric-Kovacic D.

Croat Med J. 2008 Aug;49(4):459-75.

11.
12.

Advances in the treatment of depression.

Holtzheimer PE 3rd, Nemeroff CB.

NeuroRx. 2006 Jan;3(1):42-56. Review.

13.

Ziprasidone therapy for post-traumatic stress disorder.

Siddiqui Z, Marcil WA, Bhatia SC, Ramaswamy S, Petty F.

J Psychiatry Neurosci. 2005 Nov;30(6):430-1.

14.

A primary care perspective of posttraumatic stress disorder for the Department of Veterans Affairs.

Ramaswamy S, Madaan V, Qadri F, Heaney CJ, North TC, Padala PR, Sattar SP, Petty F.

Prim Care Companion J Clin Psychiatry. 2005;7(4):180-7; quiz 188-9.

Supplemental Content

Support Center